Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factors in Patients From NRG Oncology/Gynecologic Oncology Group Random

Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factors in Patients From NRG Oncology/Gynecologic Oncology Group Random

Item

http://www.wikidata.org/entity/Q30357976

Q30357976

about

Profile of bevacizumab and its potential in the treatment of cervical cancer Predicting the survival of patients with small bowel neuroendocrine tumours: comparison of 3 systems.Validation of Nomograms for Survival and Metastases after Hysterectomy and Adjuvant Therapy in Uterine Cervical Cancer with Risk Factors.[(18)F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy Chemotherapy and molecular targeting therapy for recurrent cervical cancer Diagnostic, therapeutic and evolutionary characteristics of cervical cancer in Department of Radiotherapy, Mohamed V Military Hospital - Rabat in Morocco.A preliminary investigation into textural features of intratumoral metabolic heterogeneity in (18)F-FDG PET for overall survival prognosis in patients with bulky cervical cancer treated with definitive concurrent chemoradiotherapy Comparison of outcomes for MR-guided versus CT-guided high-dose-rate interstitial brachytherapy in women with locally advanced carcinoma of the cervix.Precision medicine in cancer: challenges and recommendations from an EU-funded cervical cancer biobanking study.Prognostic models for locally advanced cervical cancer: external validation of the published models.Nomogram for predicting recurrence in stage II colorectal cancer.Comparing treatment outcomes of stage IIIB cervical cancer patients between those with and without lower third of vaginal invasion Prediction of outcome using pretreatment 18F-FDG PET/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy.A post-recurrence survival-predicting indicator for cervical cancer from the analysis of 165 patients who developed recurrence.LINP1 facilitates DNA damage repair through non-homologous end joining (NHEJ) pathway and subsequently decreases the sensitivity of cervical cancer cells to ionizing radiation.Survival Nomograms After Curative Neoadjuvant Chemotherapy and Radical Surgery for Stage IB2-IIIB Cervical Cancer.Prophylactic Extended-Field Irradiation for Patients With Cervical Cancer Treated With Concurrent Chemoradiotherapy: A Propensity-Score Matching Analysis Textural features of cervical cancers on FDG-PET/CT associate with survival and local relapse in patients treated with definitive chemoradiotherapy Combined pretreatment with F-FDG PET/CT and Comet assay guides the concurrent chemoradiotherapy of locally advanced cervical cancer: study protocol for a randomized controlled trial

P2860

Q26774168-5175FAF8-4BE9-4CD2-AE58-FC03F3F467DC Q33656484-22B62743-A2FF-49D9-8238-8F1C8CFE6561 Q33659857-02F482AB-23DA-4E05-BAD6-9FF8DAE37C9E Q36691460-7FD75219-E503-48B8-939A-B06FC081F680 Q36897266-1F2D2EAF-FDB2-46CE-8288-34594E38DE40 Q36937795-A68935E5-E623-4AB8-B3D5-D5E6AD200D52 Q37136741-0092C7C2-6AF3-4D59-91CD-D818EC339D53 Q38894213-AD90768B-DFF8-4B7A-AF2F-0CE2281EE0D4 Q39163320-1490D283-EBE7-49DF-89CC-1E4656CEE695 Q39402065-E67B66D4-26BA-4DF9-BCB7-7BEAA75DB429 Q39434378-1BAAF97B-F57E-4F8C-BF3C-AE554A40D726 Q42700306-19AF2F7A-AEAD-40D5-ADDC-D3580C8B11B7 Q47582480-2AB3C0BD-9FF9-46FD-B7A9-242F1BC39074 Q50027830-83B3E329-3FAC-49D6-B01D-A66AE7553626 Q52727222-2FA987A6-7BEF-4D20-ABC3-1D9BFA00D276 Q53777486-112AE090-686D-4DE0-BCA2-3D161CC85F83 Q58692460-C76644A1-45AC-4552-BF40-FBFB658232EE Q58795962-26D25EB3-F70C-4343-ACEB-A6AB6A74E243 Q58801380-D454C1E8-A3BA-40D8-9931-1B556501815A

P2860

Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factors in Patients From NRG Oncology/Gynecologic Oncology Group Random

Item

http://www.wikidata.org/entity/Q30357976

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu